LOX and rectal cancer: mIHC was performed on tumour specimens obtained from patients diagnosed with gastric and rectal cancer, aiming to investigate the association between the expression levels of LOX and LOXL2 and the presence of CAFs expressing α‐SMA, as well as TAMs expressing CD68 and CD206.